Positioning

Age-Related Macular Degeneration (AMD) Therapeutics Market Size to Grow by USD 7.92 billion | High Prevalence of AMD to Drive Growth | Technavio – PR Newswire

future-dyanmics

Searching for your content…
In-Language News
Contact Us
888-776-0942
from 8 AM – 10 PM ET
News provided by
Jun 02, 2022, 08:30 ET
Share this article
NEW YORK, June 2, 2022 /PRNewswire/ — The age-related macular degeneration (AMD) therapeutics market will be driven by factors such as the high prevalence of AMD. The prevalence of AMD is high owing to the presence of high-risk factors, such as aging, smoking, high cholesterol, and high blood pressure. According to the CDC, AMD is the leading cause of blindness globally and vision loss and blindness in people aged 65 years and above.
The age-related macular degeneration (AMD) therapeutics market size is expected to grow by USD 7.92 billion from 2020 to 2025. Moreover, the growth momentum of the market will accelerate at a CAGR of 11.96% during the forecast period.
Request Latest Sample Report for additional highlights related to the growth of the age-related macular degeneration (AMD) therapeutics market
The age-related macular degeneration (AMD) therapeutics market report covers the following areas:
Subscribe to our "Basic Plan" billed annually at USD 5000. Get lifetime access to our Technavio Insights
The age-related macular degeneration (AMD) therapeutics market is fragmented and the vendors are deploying organic and inorganic growth strategies to compete in the market.
Alkeus Pharmaceuticals Inc., Allegro Ophthalmics LLC, Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Outlook Therapeutics Inc., and Reliance Industries Ltd. are among some of the major market participants.
To learn more about key vendors operating in the age-related macular degeneration (AMD) therapeutics market and their offerings, Download a Sample Report
Related Reports
Automated Microscopy Market by Type and Geography – Forecast and Analysis 2022-2026
Single-use Bioprocessing System Market by Product, Application, End-user, and Geography – Forecast and Analysis 2022-2026
Age-Related Macular Degeneration (AMD) Therapeutics Market Scope
Report Coverage
Details
Page number
120
Base year
2020
Forecast period
2021-2025
Growth momentum & CAGR
Accelerate at a CAGR of 11.96%
Market growth 2021-2025
USD 7.92 billion
Market structure
Fragmented
YoY growth (%)
10.80
Regional analysis
North America, Europe, Asia, and ROW
Performing market contribution
North America at 40%
Key consumer countries
US, Canada, Germany, China, and UK
Competitive landscape
Leading companies, competitive strategies, consumer engagement scope
Companies profiled
Alkeus Pharmaceuticals Inc., Allegro Ophthalmics LLC, Amgen Inc., Apellis Pharmaceuticals Inc., Bausch Health Companies Inc., Bayer AG, F. Hoffmann-La Roche Ltd., Novartis AG, Outlook Therapeutics Inc., and Reliance Industries Ltd.
Market Dynamics
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID 19 impact and future consumer dynamics, market condition analysis for the forecast period,
Customization purview
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.
***1. Executive Summary                         
***2. Market Landscape                            
               **2.1 Market ecosystem             
                              *Exhibit 01:  Parent market
                              *Exhibit 02:  Market characteristics
               **2.2 Value chain analysis           
                              *Exhibit 03:  Value Chain Analysis: Life sciences tools and services
                              *2.2.1 Research and development
                              *2.2.2 Inputs
                              *2.2.3 Production
                              *2.2.4 Distribution
                              *2.2.5 Marketing and sales
                              *2.2.6 Post-sales and services
                              *2.2.7 Industry innovations
***3. Market Sizing                      
               **3.1 Market definition
                              *Exhibit 04:  Offerings of vendors included in the market definition
               **3.2 Market segment analysis  
                              *Exhibit 05:  Market segments
               **3.3 Market size 2020 
               **3.4 Market outlook: Forecast for 2020 – 2025 
                              *Exhibit 06:  Global – Market size and forecast 2020 – 2025 ($ million)
                              *Exhibit 07:  Global market: Year-over-year growth 2020 – 2025 (%)
***4. Five Forces Analysis                         
               **4.1 Five Forces Summary         
                              *Exhibit 08:  Five forces analysis 2020 & 2025
               **4.2 Bargaining power of buyers            
                              *Exhibit 09:  Bargaining power of buyers
               **4.3 Bargaining power of suppliers        
                              *Exhibit 10: Bargaining power of suppliers
               **4.4 Threat of new entrants     
                              *Exhibit 11:  Threat of new entrants
               **4.5 Threat of substitutes          
                              *Exhibit 12: Threat of substitutes
               **4.6 Threat of rivalry   
                              *Exhibit 13: Threat of rivalry
               **4.7 Market condition 
                              *Exhibit 14:  Market condition – Five forces 2020
***5. Market Segmentation by Type                    
               **5.1 Market segments
                              *The segments covered in this chapter are:
                              *Exhibit 15:  Type – Market share 2020-2025 (%)
               **5.2 Comparison by Type          
                              *Exhibit 16:  Comparison by Type
               **5.3 Wet AMD – Market size and forecast 2020-2025    
                              *Exhibit 17:  Wet AMD – Market size and forecast 2020-2025 ($ million)
                              *Exhibit 18:  Wet AMD – Year-over-year growth 2020-2025 (%)
               **5.4 Dry AMD – Market size and forecast 2020-2025      
                              *Exhibit 19:  Dry AMD – Market size and forecast 2020-2025 ($ million)
                              *Exhibit 20:  Dry AMD – Year-over-year growth 2020-2025 (%)
               **5.5 Market opportunity by Type          
                              *Exhibit 21:  Market opportunity by Type
***6. Customer landscape                        
                              *Technavio’s customer landscape matrix comparing Drivers or price sensitivity, Adoption lifecycle, importance in customer price basket, Adoption rate and Key purchase criteria
                              *Exhibit 22:  Customer landscape
***7. Geographic Landscape                    
               **7.1 Geographic segmentation
                              *The regions covered in the report are:
                              *Exhibit 23:  Market share by geography 2020-2025 (%)
               **7.2 Geographic comparison    
                              *Exhibit 24:  Geographic comparison
               **7.3 North America – Market size and forecast 2020-2025          
                              *Exhibit 25:  North America – Market size and forecast 2020-2025 ($ million)
                              *Exhibit 26:  North America – Year-over-year growth 2020-2025 (%)
               **7.4 Europe – Market size and forecast 2020-2025         
                              *Exhibit 27:  Europe – Market size and forecast 2020-2025 ($ million)
                              *Exhibit 28:  Europe – Year-over-year growth 2020-2025 (%)
               **7.5 Asia – Market size and forecast 2020-2025
                              *Exhibit 29:  Asia – Market size and forecast 2020-2025 ($ million)
                              *Exhibit 30:  Asia – Year-over-year growth 2020-2025 (%)
               **7.6 ROW – Market size and forecast 2020-2025             
                              *Exhibit 31:  ROW – Market size and forecast 2020-2025 ($ million)
                              *Exhibit 32:  ROW – Year-over-year growth 2020-2025 (%)
               **7.7 Key leading countries        
                              *Exhibit 33:  Key leading countries
               **7.8 Market opportunity by geography
                              *Exhibit 34:  Market opportunity by geography ($ million)
***8. Drivers, Challenges, and Trends                  
               **8.1 Market drivers      
                              *8.1.1 High prevalence of AMD
                              *8.1.2 Rising approvals of therapeutics for AMD
                              *8.1.3 Rising geriatric population
               **8.2 Market challenges              
                              *8.2.1 Lack of approved therapies for dry AMD
                              *8.2.2 Side effects of available therapeutics
                              *Exhibit 35:  Side effects of AMD therapeutics
                              *8.2.3 Expiry of patents on major therapeutics
                              *Exhibit 36:  Impact of drivers and challenges
               **8.3 Market trends      
                              *8.3.1 Strategic alliances
                              *8.3.2 Development of gene therapy for AMD
                              *8.3.3 Growing awareness about AMD
***9. Vendor Landscape                            
                              *Exhibit 37:  Vendor landscape
               **9.1 Landscape disruption         
                              *Exhibit 38:  Landscape disruption
                              *Exhibit 39:  Industry risks
               **9.2 Competitive Scenario        
***10. Vendor Analysis               
               **10.1 Vendors covered              
                              *Exhibit 40:  Vendors covered
               **10.2 Market positioning of vendors    
                              *Exhibit 41: Market positioning of vendors
               **10.3 Alkeus Pharmaceuticals Inc.         
                              *Exhibit 42:  Alkeus Pharmaceuticals Inc.  – Overview
                              *Exhibit 43:  Alkeus Pharmaceuticals Inc.  – Product and service
                              *Exhibit 44:  Alkeus Pharmaceuticals Inc.  – Key offerings
               **10.4 Allegro Ophthalmics LLC
                              *Exhibit 45:  Allegro Ophthalmics LLC – Overview
                              *Exhibit 46:  Allegro Ophthalmics LLC – Product and service
                              *Exhibit 47:  Allegro Ophthalmics LLC – Key offerings
               **10.5 Amgen Inc.
                              *Exhibit 48:  Amgen Inc. – Overview
                              *Exhibit 49:  Amgen Inc. – Business segments
                              *Exhibit 50:  Amgen Inc. – Key offerings
               **10.6 Apellis Pharmaceuticals Inc.        
                              *Exhibit 51:  Apellis Pharmaceuticals Inc. – Overview
                              *Exhibit 52:  Apellis Pharmaceuticals Inc. – Product and service
                              *Exhibit 53:  Apellis Pharmaceuticals Inc. – Key offerings
               **10.7 Bausch Health Companies Inc.    
                              *Exhibit 54:  Bausch Health Companies Inc. – Overview
                              *Exhibit 55:  Bausch Health Companies Inc. – Business segments
                              *Exhibit 56:  Bausch Health Companies Inc. – Key news
                              *Exhibit 57:  Bausch Health Companies Inc. – Key offerings
                              *Exhibit 58:  Bausch Health Companies Inc. – Segment focus
               **10.8 Bayer AG             
                              *Exhibit 59:  Bayer AG – Overview
                              *Exhibit 60:  Bayer AG – Business segments
                              *Exhibit 61:  Bayer AG – Key offerings
                              *Exhibit 62:  Bayer AG – Segment focus
               *10.9 F. Hoffmann-La Roche Ltd.
               *Exhibit 63:  F. Hoffmann-La Roche Ltd. – Overview          
               *Exhibit 64:  F. Hoffmann-La Roche Ltd. – Business segments        
               *Exhibit 65:  F. Hoffmann-La Roche Ltd. – Key offerings   
               *Exhibit 66:  F. Hoffmann-La Roche Ltd. – Segment focus
               **10.10 Novartis AG      
                              *Exhibit 67:  Novartis AG – Overview
                              *Exhibit 68:  Novartis AG – Business segments
                              *Exhibit 69:  Novartis AG – Key offerings
                              *Exhibit 70:  Novartis AG – Segment focus
               **10.11 Outlook Therapeutics Inc.          
                              *Exhibit 71:  Outlook Therapeutics Inc.  – Overview
                              *Exhibit 73:  Outlook Therapeutics Inc.  – Key offerings
               **10.12 Reliance Industries Ltd.
                              *Exhibit 74:  Reliance Industries Ltd. – Overview
                              *Exhibit 75:  Reliance Industries Ltd. – Business segments
                              *Exhibit 76:  Reliance Industries Ltd. – Key offerings
                              *Exhibit 77:  Reliance Industries Ltd. – Segment focus
***11. Appendix                           
               **11.1 Scope of the report         
                              *11.1.1 Market definition
                              *11.1.2 Objectives
                              *11.1.3 Notes and caveats
               **11.2 Currency conversion rates for US$            
                              *Exhibit 78:  Currency conversion rates for US$
               **11.3 Research Methodology   
                              *Exhibit 79:  Research Methodology
                              *Exhibit 80:  Validation techniques employed for market sizing
                              *Exhibit 81:  Information sources
               **11.4 List of abbreviations        
                              *Exhibit 82:  List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
SOURCE Technavio
More news releases in similar topics
Cision Distribution 888-776-0942
from 8 AM – 9 PM ET

source

future-dyanmics

Related posts
Positioning

The new position driving Ohio State’s defense means maybe new stars will emerge: Doug Lesmerises - cleveland.com

Ohio State defensive coordinator Jim Knowles shows off a tackling technique on the first day of…
Read more
Positioning

How To Position For Market Cycles - Seeking Alpha

AerialPerspective WorksAerialPerspective WorksThis model provides a framework for managing your…
Read more
Positioning

Starlink satellites can be reverse-engineered to create new GPS - Freethink

SpaceX’s Starlink satellites could become a new global positioning system for the US Army…
Read more
Newsletter
Join THE PRO PEOPLE Family

Sign up for The Pro People Community's Daily Digest and get the best of Industry updates, tailored for you.

Leave a Reply

Your email address will not be published. Required fields are marked *